Jump to content

Recommended Posts

Posted

Morning,

A query for PCUK:

Is there any update regarding the CDF's 2015 delisting of Abraxane for patients in England. I believe that NICE is meant to be reviewing this disgraceful situation?


Thanks

W&M

PCUK Nurse Jeni
Posted

Hello W&M,


Thanks for your query.


Pancreatic Cancer UK are aware that this is on the agenda for NICE to be re-appraised however we have not been given a date at this point in time. We will update once we have some confirmation from NICE.


Kind regards,


Jeni.

Jeni Jones

Pancreatic Cancer Specialist Nurse

Support Team

Pancreatic Cancer UK

email: support@pancreaticcancer.org.uk

support line: 0808 801 0707

Posted

Many thanks Jeni, I hope we hear soon and that it's something to celebrate.


I've seen numerous U.S. articles recently that refer to Abraxane (with Gemcitabine) as being/becoming the standard of care. It's so galling that it's only available in England to private patients and those on trials.


Best wishes

W&M

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.